If a researcher introduces a drug that inhibits osteoclast activity in a 70-year-old patient with age-related bone loss, what effect dominates on bone density over the long term?

💡 Explanation

Osteoclasts break down bone; therefore, inhibiting them increases bone density because the balance shifts towards bone formation, causing reduced bone remodeling, rather than continuing bone breakdown. It's remodeling that's affected, rather than solely porosity because the imbalance disrupts the natural bone turnover cycle.

• If a patient with a spinal cord injury loses the ability to shiver below the injury site during cold exposure, which consequence follows regarding body temperature regulation?
• Why does bone mineral density reduce more drastically in the femoral neck compared to the lumbar spine under prolonged microgravity conditions?
• Which outcome results when cholinesterase inhibitors are overdosed?
• If a patient's melatonin production is suppressed during the evening, which consequence follows concerning sleep architecture?
• If a novel virus infects human lung cells, triggering massive chemokine release that overwhelms local immune regulation, which consequence follows?
• If a patient exhibits chronic pain despite normal tissue repair, which mechanism of pain modulation is most likely impaired?